What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health
What You Should Know:
- Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space.
- Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm.
- With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More
One Drop Acquires Sano’s Continuous Glucose Sensing Platform
What You Should Know:
- One Drop has acquired all the assets and intellectual property of Sano Intelligence, Inc. which include Sano's continuous glucose sensing platform.
- One Drop will leverage the acquired assets, including silicon-sensing production infrastructure, to design, produce, and commercialize a painless, silicon-based continuous health sensing platform for use across multiple conditions.
One Drop, a New York
City-based provider of digital care solutions for people
Read More
Analysis: Applying AI in the Fight Against The Coronavirus
Drug discovery is a notoriously long, complex and expensive process requiring the concerted efforts of the world’s brightest minds. The complexity in understanding human physiology and molecular mechanisms is increasing with every new research paper published and for every new compound tested. As the world is facing a new challenge in trying to both adapt to and defend itself against the coronavirus, artificial intelligence is offering new hope that a cure might be developed faster than ever
Read More
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know:
- More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic.
- The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
Hong Kong’s Dept. of Health Taps Biofourmis’ Remote Monitoring Platform to Fight Coronavirus
What You Need to Know:
- Boston-based Biofourmis’ AI-powered digital therapeutics technology has inked a deal with The University of Hong Kong and Hong Kong’s Department of Health to leverage its wearable, AI-powered remote monitoring platform to provide new insights to fight COVID-19 in a national disease monitoring program.
- Biofourmis’ technology will remotely monitor coronavirus infected and suspected patients and apply personally predictive analytics to help patients and increase
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Precision Health Startup Q Bio Emerges Out of Stealth with $40M Led by Andreessen Horowitz
- Precision health startup Q Bio emerges out of stealth mode, raising $40M in Series B funding led by Andreessen Horowitz to bring preventative health and the physical of the future to masses.
- In 75 minutes or less, members are able to get a comprehensive picture of their health and receive a web-based dashboard that they can review from anywhere in the world with their chosen clinicians.
Q Bio, a Redwood
City, CA-based quantitative, clinically relevant assessment of personal
Read More
Notable Launches Observational Clinical Trial for Patients with Blood Cancer
- Notable launches The ANSWer Study, it's new observational clinical trial for patients with blood cancer and is currently enrolling patients.- The primary assessment is to establish a tumor registry with annotated clinical outcomes.Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances drug development, is currently enrolling patients in its new observational clinical trial. The clinical trial will take place at
Read More
7 Trends Impacting The Design of Healthcare Environments in 2020
SmithGroup one of the nation’s leading integrated design firms has tapped its broad network of 1,300 interdisciplinary design professionals to offer its predictions for the trends and challenges that the design industry will face in the decade ahead. Here are seven trends that are likely to impact the design of health care environments in the 2020s. 1. Adapting to the Climate Crisis“In the last couple of years, the impacts of climate change are increasingly viewed as a global crisis, and I
Read More
